Glatiramer acetate vs placeboMean number of relapses ‐ at 2 years of · people with multiple sclerosis1 finding from 1 reviewGlatiramer acetate for multiple sclerosis 2010 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 298 participantsGRADE not reported